Neurimmune develops innovative immunotherapeutics for human diseases.
Business Model:
Revenue: $2.5M
Employees: 51-200
Address: Wagistrasse 18
City: Zürich
State: zurich
Zip: 8952
Country: CH
Neurimmune is a biopharmaceutical company dedicated to the development of immunotherapeutics for the treatment and prevention of human disorders with high unmet medical needs. With its unique Reverse Translational Medicine™ platform, Neurimmune creates recombinant human-derived monoclonal antibodies with biophysical characteristics closely resembling those occurring in healthy elderly. These antibodies display unique properties such as target selectivity, superior pharmacodynamics and low immunogenicity, resulting in superior risk profiles and excellent efficacy. Neurimmune’s pipeline comprises programs for a broad variety of disease related targets and specific target conformations. These include misfolded, oligomeric, fibrillar or post-translationally modified forms of disease-associated proteins as well as physiological conformations involved in major disease pathways.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2019 | NovaGo Therapeutics | Series A | 0 |
12/2016 | AL-S Pharma | Seed Round | - |
3/2019 | NovaGo Therapeutics | Series A | 0 |
12/2016 | AL-S Pharma | Seed Round | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Venture Round | 1 | $150M |
Biogen Idec Biogen Idec |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|